HealthEquity, Inc. $HQY Shares Purchased by California State Teachers Retirement System

California State Teachers Retirement System lifted its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 23.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 100,604 shares of the company’s stock after buying an additional 19,288 shares during the quarter. California State Teachers Retirement System’s holdings in HealthEquity were worth $8,407,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Acumen Wealth Advisors LLC acquired a new position in HealthEquity during the fourth quarter worth $27,000. Caitong International Asset Management Co. Ltd lifted its holdings in HealthEquity by 1,723.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after purchasing an additional 293 shares in the last quarter. Aster Capital Management DIFC Ltd acquired a new position in shares of HealthEquity in the 4th quarter valued at $28,000. Leonteq Securities AG raised its position in shares of HealthEquity by 159.9% in the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after buying an additional 235 shares during the period. Finally, Torren Management LLC acquired a new position in shares of HealthEquity in the 4th quarter valued at about $40,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Trading Up 0.6%

HealthEquity stock opened at $104.97 on Wednesday. The company’s fifty day moving average price is $92.42 and its two-hundred day moving average price is $85.41. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. HealthEquity, Inc. has a one year low of $72.76 and a one year high of $105.96. The company has a market capitalization of $8.78 billion, a price-to-earnings ratio of 39.31, a PEG ratio of 1.75 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.11 by $0.13. The company had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.HealthEquity’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, analysts forecast that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently commented on HQY. Royal Bank Of Canada boosted their price target on HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a research report on Wednesday, June 3rd. Citigroup reaffirmed a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st. BTIG Research increased their target price on shares of HealthEquity from $110.00 to $115.00 and gave the company a “buy” rating in a research report on Friday, July 24th. Weiss Ratings raised HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, June 5th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $110.00 target price on shares of HealthEquity in a report on Friday, May 22nd. Eleven analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, HealthEquity currently has an average rating of “Moderate Buy” and a consensus price target of $110.93.

Insider Activity at HealthEquity

In other HealthEquity news, Director Gayle Furgurson Wellborn sold 2,439 shares of the business’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $219,510.00. Following the transaction, the director directly owned 19,733 shares in the company, valued at $1,775,970. The trade was a 11.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the sale, the executive vice president owned 91,141 shares in the company, valued at $8,202,690. The trade was a 7.60% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 17,905 shares of company stock valued at $1,651,280 in the last 90 days. 1.60% of the stock is owned by corporate insiders.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.